CoChat

Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial

Open access
Lewis, Eldrin F., Claggett, Brian, Shah, Amil M., Liu, Jiankang, Shah, Sanjiv J., Anand, Inder, O’Meara, Eileen, Sweitzer, Nancy K., Rouleau, Jean L., Fang, James C., Desai, Akshay S., Retta, Tamrat M., Solomon, Scott D., Heitner, John F., Stamos, Thomas D., Boineau, Robin, Pitt, Bertram, Pfeffer, Marc A. · 2018 · Circulation: Heart Failure
Cited by 52

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Black patients have been shown to have different baseline characteristics and outcomes compared with nonblack patients in cohort studies. However, few studies have focused on heart failure (HF) with preserved ejection fraction (HFpEF) patients. We aimed to determine the difference in cardiovascular outcomes in black and nonblack patients with HFpEF and to determine the relative efficacy and safety of spironolactone in black and nonblack patients. Methods and Results: Patients with HFpEF, randomized to spironolactone versus placebo in the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) in North and South America, were grouped according to self-described black and nonblack race. Black HFpEF patients (n=302) were younger and were more likely to have diabetes mellitus and hypertension than nonblack patients but had similar HFpEF severity. Black patients had higher risk for the primary outcome (hazard ratio [HR], 1.34; 95% confidence interval, 1.06–1.71; P =0.02) and first HF hospitalization (HR, 1.51; 95% confidence interval, 1.167–1.97; P =0.002)], but no significant difference in cardiovascular mortality risk (HR, 0.78; 95% confidence interval, 0.51–1.20; P =0.326). In black and nonblack patients, randomization to spironolactone conferred similar efficacy in the primary outcome (HR, 0.83 versus 0.79; P for interaction=0.49), HF hospitalization (HR, 0.67 versus 0.82; P for interaction=0.76), and cardiovascular mortality ( P for interaction=0.19). The risk of hyperkalemia and worsening renal function with spironolactone and study drug adherence were also similar. Conclusions: Black patients with HFpEF have a higher HF hospitalization risk than nonblack patients, but spironolactone is similarly effective and safe in both groups. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT00094302.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.117.004457

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 52

Metadata

Authors
Lewis, E. F., Claggett, B., Shah, A. M., Liu, J., Shah, S. J., Anand, I., O’Meara, E., Sweitzer, N. K., Rouleau, J. L., Fang, J. C., Desai, A. S., Retta, T. M., Solomon, S. D., Heitner, J. F., Stamos, T. D., Boineau, R., Pitt, B., & Pfeffer, M. A.
Venue
Circulation: Heart Failure
Published
2018-03
Volume
11
Issue
3
Pages
e004457-e004457
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2790616177
Cited by
52
References
9
FWCI
3.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. https://app.cochat.ai/papers/10.1161/circheartfailure.117.004457
The paper
Lewis, E. F., Claggett, B., Shah, A. M., Liu, J., Shah, S. J., Anand, I., O’Meara, E., Sweitzer, N. K., Rouleau, J. L., Fang, J. C., Desai, A. S., Retta, T. M., Solomon, S. D., Heitner, J. F., Stamos, T. D., Boineau, R., Pitt, B., & Pfeffer, M. A. (2018). Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.117.004457

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.